Follow
Biomarkers
Biomarkers: a biomarker, or biological marker, generally refers to a measurable indicator of some biological state or condition. The term is also occasionally used to refer to a substance, the presence of which indicates the existence of a living organism. Further, life forms are known to shed unique chemicals, including DNA, into the environment as evidence of their presence in a particular location.
NOV 06, 2025 | 10:00 AM
C.E. CREDITS
Discover how MSK-IMPACT® Flex with SOPHiA DDM™ enables modular, cost-efficient genomic profiling with flexible DNA/RNA biomarker analysis....
OCT 23, 2025 | 10:00 AM
Cancer care has been transformed by comprehensive molecular profiling and targeted therapies—but with improvements in sample analysis technologies, the volume of information and burden...
OCT 21, 2025 | 7:00 AM
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulatin...
OCT 17, 2025 | 8:00 AM
Hepatobiliary cancers, including hepatocellular carcinoma (HCC) and gallbladder cancer (GBC), are strongly linked to chronic inflammation. Recent research using the Olink PEA Technology sugg...
SEP 17, 2025 | 7:00 AM
Neurodegenerative diseases are among the most complex and urgent challenges in medicine, characterized by their heterogeneity, limited available biomarkers, and lack of effective treatments....
SEP 11, 2025 | 9:00 AM
C.E. CREDITS
Millions of women globally struggle with infertility and often face difficulties accessing necessary medical support. Some conditions that contribute to female infertility include polycystic...
SEP 10, 2025 | 11:00 AM
Brain-derived extracellular vesicle (EV) biomarkers represent a promising frontier for liquid biopsy development targeting the nervous system. They offer strong potential for enabling minima...
SEP 09, 2025 | 7:00 AM
Early detection and molecular characterization of disease progression are persistent challenges in modern medicine. Although genomic and transcriptomic profiling of tissue lesions and precur...
July 31, 2025 7am PST/10am EST/4pm CET
microRNAs are emerging as powerful biomarkers for precision medicine, offering valuable insights into disease mechanisms, diagnosis, prognosis, and treatment response. However, successful di...
JUL 16, 2025 | 8:00 AM
The identification of reliable biomarkers from peripheral blood is crucial for improving disease diagnosis and monitoring. Spectral flow cytometry has emerged as a powerful tool for high-dim...
JUN 25, 2025 | 11:00 PM
Learn how blood-based multiomics reveals tumor-specific biomarkers in pediatric cancers, aiding personalized immunotherapy-without invasive biopsies....
JUN 25, 2025 | 8:00 AM
Traumatic brain injury, together with adjacent brain conditions such as Alzheimer’s disease, is a global health crisis. In this presentation, Aleksandra Hemm, Product Manager from Ther...
JUN 17, 2025 | 8:00 AM
Biomarkers are no longer just exploratory tools-they're becoming strategic assets in drug development and clinical trials. Join a panel of industry thought leaders as they explore how biomar...
JUN 11, 2025 | 8:00 AM
Advances in tissue-based technology in the past few years have created unprecedented opportunities to identify biomarkers of disease processes, especially within oncology by using multi-omic...
JUN 10, 2025 | 6:00 AM
Personalized health profiling using multi-omics data has the potential to reveal immunometabolic disruptions among individuals living with HIV (PWH) who are effectively undergoing antiretrov...
MAY 28, 2025 | 8:00 AM
Join us for an insightful session where we explore how NGS proteomics is transforming our understanding of health and disease. Discover how proteomics integrates seamlessly with genomics, me...
MAY 15, 2025 | 9:00 AM
The immune system is dynamic and multifaceted, making the discovery of meaningful biomarkers and the study of disease a significant challenge. The leadership at Talon Biomarkers has a long h...
MAY 13, 2025 | 9:00 AM
Immune checkpoint blockade (ICB) targeting T cells has enhanced clinical outcomes in patients with renal and bladder cancers; however, response rates remain limited, particularly in cases of...